İlKer Sen

İlKer Sen

Auto-generated profile, based on publicly available information

İlKer Sen

Department of Gastroenterology, Şişli Hamidiye Etfal Education and Research Hospital, İstanbul, Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Hepatology Forum
Verified
Journal Article
Open access
PDF file
Yusuf YilmazYusuf Yilmaz
Yusuf Yilmaz
NYNimet Yilmaz
Nimet Yilmaz
FAFehmi Ates
Fehmi Ates
FKFatih Karakaya
Fatih Karakaya
HGHale Gokcan
Hale Gokcan
RIRamazan İdIlman
Ramazan İdIlman
Background and Aim: The objective of the present study was to investigate the prevalence of metabolic-associated fatty liver disease (MAFLD) in patients with dyspepsia. Materials and Methods: A total of 909 consecutive patients who presented with dyspepsia at 8 tertiary care centers in Turkey between March 2019 and December 2019 were included. Results: The median age was 47 years. Among them, 30.3% of the patients were obese, 18.8% had type 2 diabetes mellitus (T2DM), 35.1% had metabolic syndrome, 84.8% had dyslipidemia, and 23.9% had hypertension. The prevalence of MAFLD was 45.5%. Among the patients with MAFLD, the prevalence of obesity, T2DM, metabolic syndrome, dyslipidemia, and hypertension was 43.3%, 24.9%, 52.5%, 92.3%, and 31.9%, respectively. MAFLD was significantly associated with all of the metabolic comorbidities (p

15 November 2024 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
DKDeniz Öğütmen Koç
Deniz Öğütmen Koç
GBGöksel Bengi
Göksel Bengi
ÖGÖzlem Gül
Özlem Gül
YAYeşim Özen Alahdab
Yeşim Özen Alahdab
EAEngin Altıntaş
Engin Altıntaş
OSOrhan Sezgin
Orhan Sezgin
Acute pancreatitis (AP) is a clinical condition that arises acutely in the pancreas through various inflammatory pathways due to multiple causes. Turkish Society of Gastroenterology Pancreas Working Group developed comprehensive guidance statements regarding the management of AP that include its epidemiology, etiology, clinical presentation, diagnostic criteria, disease severity, treatment, prognosis, local and systemic complications. The statements were developed through literature review, deliberation, and consensus opinion. These statements were ultimately used to develop a conceptual framework for the multidisciplinary management of AP. Cite this article as: Öğütmen Koç D, Bengi G, Gül Ö, et al. Turkish society of gastroenterology: Pancreas working group, acute pancreatitis committee consensus report. Turk J Gastroenterol. 2024;35(S1):S1-S44.

13 October 2023 in Pancreatology
Verified
Journal Article
Closed access
AKAydın Şeref Köksal
Aydın Şeref Köksal
MTMukaddes Tozlu
Mukaddes Tozlu
OSOrhan Sezgin
Orhan Sezgin
DODilek Oğuz
Dilek Oğuz
İKİsmail Hakkı Kalkan
İsmail Hakkı Kalkan
EPErkan Parlak
Erkan Parlak

15 March 2024 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
MTMustafa Tahtaci
Mustafa Tahtaci
EYEmre Yıldırım
Emre Yıldırım
EÜEnver Üçbilek
Enver Üçbilek
IŞİlKer Şen
İlKer Şen
GBGülden Bilican
Gülden Bilican
TKTarkan Karakan
Tarkan Karakan
Background/Aims: Gastroenterologists have an important role in the treatment and management of comorbidities related to obesity. Assessment of gastroenterologists perception and attitude toward obesity was aimed in this study. Materials and Methods: Survey questions were determined for the study. An online questionnaire was prepared afterward. Participants were invited via e-mail by providing them with information about the study. It was ensured that those who accepted the study could access the questionnaire form with the relevant link. Participants who answered all questions were included in the study. Results: Totally 117 gastroenterologists were included in the study. The proportion of gastroenterologists who thought that obesity complicates the management of gastroenterological diseases and those who thought obesity as a factor that negatively affects the prognosis of gastroenterological diseases was determined as 88.9% and 95.7%, respectively. Among the obese patients, the proportion of those who applied diet therapy, exercise, pharmacotherapy, and endoscopic methods was 94%, 91.5%, 35%, and 37.6%, respectively. The rates of intragastric balloon therapy and intragastric botulinum toxin A injection were 30% and 21.4%, respectively. The proportion of those who agreed that obese patients lost a significant amount of weight with the treatment methods applied was 47.2%. The proportion of participants who agreed that long-term maintenance of weight loss was impossible for most obese patients was 59.8%. Conclusion: To our knowledge, this is the first study that evaluates the perception and attitude of gastroenterologists toward obesity. Our study results show that gastroenterologists think that obesity is a chronic disease and that gastroenterologists should be involved in management of obesity. Cite this article as: Tahtacı M, Yıldırım E, Ç bilek E, et al. Perception and attitude of Turkish gastroenterologists toward obesity: A nationwide survey conducted by the Obesity Study Group of the Turkish Gastroenterology Association. Turk J Gastroenterol. 2024;35(3):161-167.

15 July 2024 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
IŞİlKer Şen
İlKer Şen
ŞDŞükrü Dumlu
Şükrü Dumlu
Background/Aims: Liver fatty acid-binding protein (LFABP) controls hepatocyte lipid metabolism and can be a biomarker in liver diseases. We compared the correlation of LFABP levels with liver histology in viral hepatitis and nonalcoholic fatty liver disease (NAFLD) and investigated the utility of serum LFABP as a biomarker for liver damage. Materials and Methods: We included 142 patients (60 chronic viral hepatitis B [CHB], 35 chronic viral hepatitis C [CHC], 47 NAFLD) and 40 healthy controls. LFABP levels were determined in all participants, and a liver biopsy was performed on patients. The nonalcoholic steatohepatitis (NASH) activity score (NAS), hepatosteatosis, liver inflammation, and fibrosis were evaluated for NAFLD patients. Ishak’s histological scores were used for viral hepatitis. The correlation between LFABP levels and histologic scores was assessed in each group. Results: Serum LFABP levels in CHB, CHC, NAFLD, and control groups were 2.2, 3.5, 7.6, and 2.1 ng/mL, respectively. LFABP levels were significantly higher in the NAFLD group compared to the control, CHC, and CHB groups. LFABP was significantly higher in the NASH group than in nonalcoholic steatohepatitis, 8 ng/mL and 5.4 ng/mL, respectively (P = .001). In the NAFLD group, LFABP levels showed a moderate positive correlation with NAS score (r = 0.58, P < .001), ballooning degeneration (r = 0.67, P < .001), and lobular inflammation (r = 0.62, P < .001). A logistic regression study showed that the level of LFABP was predictive of NASH independent of age, gender, homeostasis model of IR, body mass index, aspartate aminotransferase, and alanine aminotransferase (OR = 1.869, P = .01). Conclusion: LFABP specifically correlates with liver histology in NAFLD compared to viral hepatitis. Additionally, it can distinguish NASH from simple steatosis. LFABP may be a valuable biomarker for hepatocyte injury in NASH. Cite this article as: Şen İ, Dumlu Ş. Liver fatty acid-binding protein is a more reliable biomarker for liver injury in non-alcoholic steatohepatitis than other etiologies of hepatitis. Turk J Gastroenterol. 2024;35(7):568-576.

1 January 2023 in Diagnostic and Interventional Endoscopy
Verified
Journal Article
Closed access
IŞİlKer Şen
İlKer Şen
AKAli Riza Koksal
Ali Riza Koksal
Objectives: There are numerous difficulties in performing endoscopic ultrasound-guided fine needle aspiration for pancreatic lesions in patients with surgically altered upper gastrointestinal anatomy. We aimed to evaluate the rate of endoscopic ultrasound-guided fine needle aspiration success in this particular population. Methods: We evaluated retrospective data of the patients with post-surgical altered upper gastrointestinal anatomy who underwent endoscopic ultrasound evaluation of the pancreatic lesions at a tertiary education hospital between December 2018 and January 2022. Results: Totally 16 patients’ data were evaluated. According to histories of the surgical procedures, 10 patients had Billroth II, 3 patients had sleeve gastrectomy, and 3 had total gastrectomy. The median patient age was 58, and 10 (62.5%) out of 16 were male. While the tissue acquisition success rate was 100% in the pancreatic body and tail lesions regardless of the type of surgery, the mean success rate was 62.5% in the pancreatic head/uncinate lesions. There was no major complication in our series. Conclusions: The yield of endoscopic ultrasound-guided fine needle aspiration is dependent on lesion location and surgery type. Before considering endoscopic ultrasound-guided fine needle aspiration in these patients, one must carefully consider whether the lesion may be accessible by endoscopic ultrasound.